Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells

Molecular Brain Research

Volumn 93, Issue 1, 2001, Pages 18-26

  Park, Sun Ah ^a   Park, Hyun Jin ^b   Lee, Byung In ^a   Ahn, Yong Ho ^a   Kim, Seung U ^b   Choi, Kyeong Sook ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Apoptosis; B104 cell; Bcl 2; Cisplatin; Extracellular signal regulated kinase; p53

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CISPLATIN; FAS ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CISPLATIN; GENE EXPRESSION; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035840335     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00176-0     Document Type: Article

References (46)

1. Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line
2. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation
3. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
4. Bcl-2 facilitates recovery from DNA damage after oxidative stress
5. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
6. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y
7. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
8. Inhibition of p53 transcriptional activity by Bcl-2 requires its membrane-anchoring domain
9. MEKK1/JNK signaling stabilizes and activates p53
10. The CD95(APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
11. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase
12. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle
13. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
14. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389
15. 2
16. Neurological complications of radiotherapy and chemotherapy
17. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53
18. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance
19. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo
20. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells
21. Neurologic complications of chemotherapy
22. Checkpoints of dueling dimers foil death wishes
23. 2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs
24. Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells
25. Activation of c-Jun N-terminal kinase antagonizes an antiapoptotic action of Bcl-2
26. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand
27. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells
28. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems
29. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin
30. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin
31. Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells
32. Bcl-2 and p53: Role in dopamine-induced apoptosis and differentiation
33. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation
34. Transgenic murine cortical neurons expressing human bcl-2 exhibit increased resistance to amyloid β-peptide neurotoxicity
35. Cisplatin induces a persistent activation of JNK that is related to cell death
36. Clonal cell lines form the rat central nervous system
37. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation
38. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
39. The cellular response to p53: The decision between life and death
40. Bcl-2 and Bcl-XL block thapsigargin-induced nitric oxide generation, c-Jun, NH2-terminal kinase activity, and apoptosis
41. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis
42. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
43. Requirement for ERK activation in cisplatin-induced apoptosis
44. The cellular response to oxidative stress: Influence of mitogen-activated protein kinase signalling pathways on cell survival
45. Opposing effects of ERK and JNK-p38 MAP kinase on apoptosis
46. Inhibitory effect of Bcl-2 on p53-mediated transactivation following genotoxic stress